These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2573210)

  • 21. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
    J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation.
    Barker TD; Weissman D; Daucher JA; Roche KM; Fauci AS
    J Immunol; 1996 Jun; 156(11):4476-83. PubMed ID: 8666823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
    AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners.
    Turner BJ; Hecht FM; Ismail RB
    Arch Intern Med; 1994 Jul; 154(14):1561-73. PubMed ID: 7913314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis, natural history, and classification of HIV infection.
    Libman H
    Prim Care; 1992 Mar; 19(1):1-17. PubMed ID: 1594691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical course of HIV disease].
    Matsumoto T
    Nihon Rinsho; 1993 Sep; 51 Suppl():249-53. PubMed ID: 7903707
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging.
    Hofmann B; Bygbjerg I; Dickmeiss E; Faber V; Frederiksen B; Gaub J; Gerstoft J; Jakobsen BK; Jakobsen KD; Lindhardt BO
    Scand J Infect Dis; 1989; 21(6):633-43. PubMed ID: 2575793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of HIV-1 infection: staging classifications of disease.
    Royce RA; Luckmann RS; Fusaro RE; Winkelstein W
    AIDS; 1991 Apr; 5(4):355-64. PubMed ID: 1676278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and immunological assessment of HIV infection.
    Bird AG
    J Clin Pathol; 1992 Oct; 45(10):850-4. PubMed ID: 1358921
    [No Abstract]   [Full Text] [Related]  

  • 33. The official AIDS caseload will grow.
    Am J Nurs; 1992 Feb; 92(2):9. PubMed ID: 1346734
    [No Abstract]   [Full Text] [Related]  

  • 34. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
    Mackewicz C; Levy JA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1039-50. PubMed ID: 1354466
    [No Abstract]   [Full Text] [Related]  

  • 35. CD4+ T-lymphocytopenia without HIV infection--no lights, no camera, just facts.
    Fauci AS
    N Engl J Med; 1993 Feb; 328(6):429-31. PubMed ID: 8093637
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological and hematological aspects of HIV infection].
    Delhougne B; Fillet G
    Rev Med Liege; 1993 Feb; 48(2):72-80. PubMed ID: 8095351
    [No Abstract]   [Full Text] [Related]  

  • 37. Contrasting quantitative alterations in CD4+ and CD8+ lymphocytes in HIV-infected African Americans compared with the Caucasian population.
    Cruse JM; Brackin MN; Lewis RE; Brackin BT
    Pathol Immunopathol Res; 1989; 8(5-6):300-13. PubMed ID: 2576689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and AIDS.
    Allen AD; Mathisen GE; Glover N; Au J
    Science; 1993 Jun; 260(5115):1706-7. PubMed ID: 8099760
    [No Abstract]   [Full Text] [Related]  

  • 39. The chronology of HIV-induced disease.
    Stewart GJ
    Med J Aust; 1993 Jan; 158(1):3-5. PubMed ID: 8093324
    [No Abstract]   [Full Text] [Related]  

  • 40. Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group.
    Aledort LM; Operskalski EA; Dietrich SL; Koerper MA; Gjerset GF; Lusher JM; Lian EC; Mosley JW
    N Engl J Med; 1993 Feb; 328(6):441-2. PubMed ID: 8093638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.